Harbor:Sepsis antibiotics: Difference between revisions

Line 45: Line 45:


*Mild HAP/HCAP no recent antibiotic exposure:  
*Mild HAP/HCAP no recent antibiotic exposure:  
**'''[[Cefepime]] '''1g IV Q8H +/- '''[[Clindamycin]] '''600mg IV '''OR''' '''[[Metronidazole]]''' if risk of aspiration
**'''[[Cefepime]] '''1g IV Q8H  
**If risk of aspiration add '''[[Clindamycin]] '''600mg IV '''OR''' '''[[Metronidazole]]'''  
*Moderate HAP/HCAP or necrotizing [[pneumonia]]:  
*Moderate HAP/HCAP or necrotizing [[pneumonia]]:  
**Add '''[[Vancomycin]] '''for [[MRSA]]
**Add '''[[Vancomycin]] '''for [[MRSA]]

Revision as of 22:55, 21 February 2019

Unknown Source[1]

Pneumonia

Community Acquired Pneumonia (CAP)

MCC by S. pneumoniae. In young must cover for mycoplasma and other atypicals. See Pneumonia (Pathogens)

Treatment based on Pneumonia (Port Score)

Healthcare Associated pneumonia (HCAP) + Hospital Associated pneumonia (HAP)

HAP occurs if patient develops pneumonia 2-3 days after hospitalization. HCAP occus in non-hospitalized patient with extensive healthcare contact.

Abdominal/Pelvic

UTI with Sepsis

Meningitis

  • Immunocompromised (Cirrhosis, EtoH, age > 65, steroids, HIV)

Necrotizing Soft-tissue Infection

Neutropenic Fever

See Also

Harbor:Antibiotics by diagnosis

See also Harbor: Sepsis core measures
Initial Antibiotics in Sepsis (Main)

References

  1. Form v2011.09.15